According to GuruFocus list of 3-year lows: Multi-Fineline Electronix Inc, NxStage Medical Inc, CVR Refining LP, and Crestwood Midstream Partners LP have all reached their 3-year lows.
Multi-Fineline Electronix, Inc. (MFLX, Financial) Reached the 3-year Low of $12.50
The prices of Multi-Fineline Electronix, Inc. (MFLX) shares have declined to close to the 3-year low of $12.50, which is 58.9% off the 3-year high of $29.99.
Multi-Fineline Electronix, Inc. has a market cap of $301.342 million; its shares were traded at around $12.50 with and P/S ratio of 0.37. Multi-Fineline Electronix, Inc. had an annual average earnings growth of 12.30% over the past 10 years. GuruFocus rated Multi-Fineline Electronix, Inc. the business predictability rank of 3-star.
In its fiscal fourth quarter 2013 ended September 30, 2013, Multi-FIneline reported net sales of $188.3 million, down 7% from net sales prior year quarter. Net loss was $18.5 million compared to breakeven income a year ago.
NxStage Medical, Inc. (NXTM, Financial) Reached the 3-year Low of $10.16
The prices of NxStage Medical, Inc. (NXTM) shares have declined to close to the 3-year low of $10.16, which is 63.3% off the 3-year high of $27.12.
Nxstage Medical, Inc. has a market cap of $619.059 million; its shares were traded at around $10.16 with and P/S ratio of 2.38.
For its third quarter of 2013, NxStage reported a revenue increase of 9% year-over-year to $66.9 million, and a net loss of $5 million compared to net loss of $2.6 million last year.
President, Kidney Care Robert S. Brown sold 140,100 shares of NXTM stock on 10/21/2013 at the average price of $14.
CVR Refining LP (CVRR, Financial) Reached the 3-year Low of $21.77
The prices of CVR Refining LP (CVRR) shares have declined to close to the 3-year low of $21.77, which is 42.2% off the 3-year high of $35.98.
CVR Refining LP has a market cap of $3.2 billion; its shares were traded at around $21.77 with a P/E ratio of 6.00 and P/S ratio of 0.39. The dividend yield of CVR Refining LP stocks is 14.88%.
CVR Refining LP reported third quarter 2013 net income of $86 million and net sales of $1.91 billion, compared to net income of $318 million and sales of $2.33 billion prior year quarter. The company claims that third quarter results were negatively affected by failure of a major piece of equipment in a refinery.
1 Guru Increased Positions: Carl Icahn owns 6,000,000 shares as of 06/30/2013, an increase of 50% from the previous quarter. This position accounts for 0.84% of the $21.52 billion portfolio of Icahn Capital Management LP.
Crestwood Midstream Partners LP (CMLP, Financial) Reached the 3-year Low of $20.62
The prices of Crestwood Midstream Partners LP (CMLP) shares have declined to close to the 3-year low of $20.62, which is 39.7% off the 3-year high of $33.00.
Crestwood Midstream Partners LP has a market cap of $1.24 billion; its shares were traded at around $20.62 with a P/E ratio of 91.60 and P/S ratio of 4.24. Crestwood Midstream Partners LP had an annual average earnings growth of 8.60% over the past 5 years.
Crestwood reported third quarter 2013 adjusted EBITDA of $100 million and net loss of $7.9 million.
Go here for the complete list of 3-year lows.
Multi-Fineline Electronix, Inc. (MFLX, Financial) Reached the 3-year Low of $12.50
The prices of Multi-Fineline Electronix, Inc. (MFLX) shares have declined to close to the 3-year low of $12.50, which is 58.9% off the 3-year high of $29.99.
Multi-Fineline Electronix, Inc. has a market cap of $301.342 million; its shares were traded at around $12.50 with and P/S ratio of 0.37. Multi-Fineline Electronix, Inc. had an annual average earnings growth of 12.30% over the past 10 years. GuruFocus rated Multi-Fineline Electronix, Inc. the business predictability rank of 3-star.
In its fiscal fourth quarter 2013 ended September 30, 2013, Multi-FIneline reported net sales of $188.3 million, down 7% from net sales prior year quarter. Net loss was $18.5 million compared to breakeven income a year ago.
NxStage Medical, Inc. (NXTM, Financial) Reached the 3-year Low of $10.16
The prices of NxStage Medical, Inc. (NXTM) shares have declined to close to the 3-year low of $10.16, which is 63.3% off the 3-year high of $27.12.
Nxstage Medical, Inc. has a market cap of $619.059 million; its shares were traded at around $10.16 with and P/S ratio of 2.38.
For its third quarter of 2013, NxStage reported a revenue increase of 9% year-over-year to $66.9 million, and a net loss of $5 million compared to net loss of $2.6 million last year.
President, Kidney Care Robert S. Brown sold 140,100 shares of NXTM stock on 10/21/2013 at the average price of $14.
CVR Refining LP (CVRR, Financial) Reached the 3-year Low of $21.77
The prices of CVR Refining LP (CVRR) shares have declined to close to the 3-year low of $21.77, which is 42.2% off the 3-year high of $35.98.
CVR Refining LP has a market cap of $3.2 billion; its shares were traded at around $21.77 with a P/E ratio of 6.00 and P/S ratio of 0.39. The dividend yield of CVR Refining LP stocks is 14.88%.
CVR Refining LP reported third quarter 2013 net income of $86 million and net sales of $1.91 billion, compared to net income of $318 million and sales of $2.33 billion prior year quarter. The company claims that third quarter results were negatively affected by failure of a major piece of equipment in a refinery.
1 Guru Increased Positions: Carl Icahn owns 6,000,000 shares as of 06/30/2013, an increase of 50% from the previous quarter. This position accounts for 0.84% of the $21.52 billion portfolio of Icahn Capital Management LP.
Crestwood Midstream Partners LP (CMLP, Financial) Reached the 3-year Low of $20.62
The prices of Crestwood Midstream Partners LP (CMLP) shares have declined to close to the 3-year low of $20.62, which is 39.7% off the 3-year high of $33.00.
Crestwood Midstream Partners LP has a market cap of $1.24 billion; its shares were traded at around $20.62 with a P/E ratio of 91.60 and P/S ratio of 4.24. Crestwood Midstream Partners LP had an annual average earnings growth of 8.60% over the past 5 years.
Crestwood reported third quarter 2013 adjusted EBITDA of $100 million and net loss of $7.9 million.
Go here for the complete list of 3-year lows.
